52 results about "Eicosapentanoic acid" patented technology

The subject invention relates to the identification of several genes involved in the elongation of polyunsaturated acids (i.e., "elongases") and to uses thereof. At least two of these genes are also involved in the elongation of monounsaturated fatty acids. In particular, elongase is utilized in the conversion of gamma linolenic acid (GLA) to dihomogamma linolenic acid (DGLA) and in the conversion of AA to adrenic acid (ADA), or eicosapentaenoic acid (EPA) to omega3-docosapentaenoic acid (DPA). DGLA may be utilized in the production of polyunsaturated fatty acids, such as arachidonic acid (AA), docosahexaenoic acid (DHA), EPA, adrenic acid, omega6-docosapentaenoic acid or omega3-docosapentaenoic acid which may be added to pharmaceutical compositions, nutritional compositions, animal feeds, as well as other products such as cosmetics.

The invention relates to a method for enriching n-3 polyunsaturated fatty acid (n-3PUFA) from fish oil, which belongs to the food organism and functional health product technical field. The method takes the fish oil as a raw material, uses the chemical hydrolysis method to hydrolyze the fish oil, respectively obtains high-purity eicosapentaenoic acid (EPA) and high-purity docosahexaenoic acid (DHA) from the hydrolyzed fish oil through separation and purification, uses glycerol and the purified EPA or DHA as raw materials and utilizes lipase to respectively catalyze and synthesize an EPA glyceride product or a DHA glyceride product in an organic phase. The products are mainly n-3PUFA triglyceride; the purity of the products is high; and the concentration of EPA triglyceride in the EPA glyceride is between 90 and 95 percent, and the concentration of DHA triglyceride in the DHA glyceride is between 92 and 94 percent. The high-purity EPA triglyceride product and the high-purity DHA triglyceride product prepared by the method well improve the application pertinence of different health care efficacies of natural fish oil products and improve the functional health care value of the fish oil products.

An orally or parenterally administered composition for reducing the storage of lipids in a human, the composition comprising: an effective amount of hydroxycitric acid; an effective amount of carnitine; an effective amount of biotin; an effective amount of one or more gluconeogenic substrates selected from the group consisting of: aspartate, lactate, glycerol, and a gluconeogenic amino acid or alphaketo analogue thereof; an effective amount of eicosapentanoic acid; and an effective amount of one or more ingredients selected from the group consisting of: medium chain triglycerides (MCT) with fatty acid backbones containing 6 to 14 carbon atoms or their individual fatty acid analogues or metabolic precursors, sesame seeds or derivative products, sesamin and/or its epimer episesamin, caffeine, forskolin, 7-keto dehydroepiandrosterone (7-keto DHEA), green tea extract containing epigallocatechingallate (EGCG), capsaicum, and 5-hydroxytryptophan (5-HTP). The supplement may also be combined with a food, beverage, condiment, spice or salad dressing base to provide a food, beverage, condiment, spice or salad dressing product designed to reduce lipid storage.

The present disclosure relates to antioxidant-stabilized composition containing at least one omega 3 polyunsaturated fatty acid (PUFA). The omega 3 PUFA may include eicosapentanoic acid, docosahexaneoic acid and combinations thereof. The compositions additionally contain an antioxidant package made from a mixture of: at least one form of vitamin E; ascorbyl palmitate; rosemary extract; and grape seed oil. The present disclosure further relates to a method of increasing the oxidative stability of concentrated fish oil.

Improved compositions and methods are useful in the treatment and prevention of impulsive, compulsive, reward-seeking, and other addictive behaviors, including applications involving the behavioral/cognitive process of assigning importance, maintaining attention, and assessing salience. The composition includes Vitex agnus-castus (Chastetree berry) extract in an effective amount for supporting and promoting a healthy lifestyle free from addictive behavior or for preventing or treating addictive behavior. The composition also includes garcinia cambogia, aspartic acid, pyruvate, EPA (eicosapentanoic acid), biotin, L-carnitine, and chromium polynicotinate.

The invention concerns a method of sustainably producing an pet food product or product, said method comprising the step of formulating a pet food product by replacing all or part of fish oil in the composition with a single microbial source of eicosapentaenoic acid (“EPA”) and docosahexaenoic acid (“DHA”). In a preferred embodiment, the microbial source comprising DHA and EPA derives from a microorganism/microbe of the genus Schizochytrium or Thraustochytrium.

The present invention relates to the continuous process of sequestration of nutrients from waste effluents released from gas fermentation plants or green-house gases emission managing plants by novel Thraustochytrids. Particularly this invention relates to the methods and systems to enhance sequestration rate and productivity of the process. This invention also relates to rapid biotransformation of nutrients present in waste effluents into high value omega-3 fatty acids like Docosahexaenoic acid (DHA), Docosapentaenoic acid (DPA), Eicosapentaenoic acid (EPA) and lipids for biodiesel. This disclosure is about means of processing of waste streams and producing value added products out of it.

The invention relates to an euphausia superba oil gel capsule and a preparation method thereof, the method comprises the following steps: (1) mixing gelatin, a softener, water and a modifier, heating and uniformly stirring to obtain a gelatin solution, the modifier being a food additive with hydroxyl; and (2) taking gelatin liquid as a capsule wall material, taking euphausia superba oil as a capsule content, and wrapping the capsule content in the capsule wall material to form a soft capsule, thereby obtaining the euphausia superba oil soft capsule. By modifying the capsule wall material, when eicosapentaenoic acid and docosahexaenoic acid in the krill oil are in contact with the inner wall of the soft capsule, hydrophilic carboxyl groups on the eicosapentaenoic acid and docosahexaenoic acid can be combined with hydroxyl groups on the inner wall surface of the soft capsule to form ester groups, and the ester groups are hydrophobic groups; and equivalently, a barrier film layer is formed on the inner wall surface of the soft capsule, so that other krill oil in the capsule can be prevented from continuously contacting with the inner wall surface of the soft capsule, and the problems of hardening and embrittlement of the soft capsule caused by water absorption of the krill oil are well avoided.

The invention provides an apostichopus japonicus and sea cucumber flower lipid extract as well as a preparation method and application thereof. The sea cucumber flower lipid extract mainly contains 20fatty acids such as eicosapentaenoic acid and docosahexaenoic acid and the like, wherein 13 unsaturated fatty acids are contained, and the relative percentage content is not less than 70%. The extracted and purified sea cucumber flower lipid extract is administrated orally, so that the total cholesterol and low-density lipoprotein of hyperlipidaemia rats can be remarkably reduced, and the effectis close to that of a positive control drug atorvastatin calcium tablet. The extracted and purified sea cucumber flower lipid extract has a remarkable effect of reducing triglyceride in serum of the hyperlipidaemia rats, the effect of reducing triglyceride is superior to that of a positive control medicine atorvastatin calcium tablet, and meanwhile, the extracted and purified sea cucumber flower lipid extract has an obvious effect of increasing high-density lipoprotein of the hyperlipidaemia rats. The sea cucumber flower lipid extract has more remarkable blood fat regulating activity than seacucumber flowers, the effect of the sea cucumber flower lipid extract is far better than that of the sea cucumber flowers, and it is prompted that the sea cucumber flower lipid extract can be appliedto research and development of hyperlipidemia regulating drugs or health-care functional foods.

The invention discloses a soft fish oil capsule comprising the following raw materials, by weight: 16 to 18 parts of eicosapentaenoic acid, 13 to 15 parts of docosahexaenoic acid, 0.1 to 0.2 part of antioxidant, 20 to 30 parts of grape seed oil, 10 to 20 parts of glycerol, 30 to 40 parts of gelatin, 4 to 6 parts of lemon oil and 6 to 8 parts of span 80. The invention also discloses a preparation method of the soft fish oil capsule. According to the invention, a proper formula is selected and a proper preparation method is matched, so that the oxidation resistance is good.

Provided is a fat or oil composition having high oxidative stability even though containing large amounts of eicosapentaenoic acid and docosahexaenoic acid, and having suppressed degradation odor and unpleasant odor derived from a rosemary extract at the time of cooking. The fat or oil composition comprises the following components (A), (B), and (C):(A) a fat or oil in which a total content of eicosapentaenoic acid and docosahexaenoic acid in constituent fatty acids of the fat or oil is from 0.1 to 20 mass % with respect to total constituent fatty acids of the fat or oil; (B) a rosemary extract; and (C) a dill extract, in which a mass ratio of a content of the component (B) to a content of the component (C), [(B)/(C)], is from 2 to 200.